Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
Majority of PI patients can be switched to IgPro20 without dose adjustment

Majority of PI patients can be switched to IgPro20 without dose adjustment

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Novo Nordisk awarded contract by VA as primary source provider of insulin

Novo Nordisk awarded contract by VA as primary source provider of insulin

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

Greffex Group signs Strategic Alliance Framework Agreement with UPMC and ISMETT

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

GTC Biotherapeutics achieves high-level production of TG20 monoclonal antibody

GTC Biotherapeutics achieves high-level production of TG20 monoclonal antibody

IgPro20 protects PI patients against infection

IgPro20 protects PI patients against infection

Baxter International to acquire outstanding equity of ApaTech for $330 million

Baxter International to acquire outstanding equity of ApaTech for $330 million

Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partnership, drug sales up 7.6%

Ipsen’s 2009 performance: Azzalure, Dysport and Decapeptyl approval, Adenuric partnership, drug sales up 7.6%

AMT announces full year 2009 results; reports modest decrease in operating expenses

AMT announces full year 2009 results; reports modest decrease in operating expenses

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients

LFB Biotechnologies provides new loan financing to GTC Biotherapeutics for key strategic programs

LFB Biotechnologies provides new loan financing to GTC Biotherapeutics for key strategic programs

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Biogen Idec, Swedish Orphan Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc programs

Biogen Idec, Swedish Orphan Biovitrum restructure collaboration agreement for rFVIIIFc and rFIXFc programs

Genzyme announces fourth-quarter and full-year 2009 financial results

Genzyme announces fourth-quarter and full-year 2009 financial results

Nebraska laws to protect patients and healthcare providers against unfair prescription insurance practices

Nebraska laws to protect patients and healthcare providers against unfair prescription insurance practices

Special issue reviews current state of science in fetal therapy

Special issue reviews current state of science in fetal therapy

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

FDA grants approval for Abbott's antiretroviral medication Norvir

FDA grants approval for Abbott's antiretroviral medication Norvir